SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001607062-20-000154
Filing Date
2020-06-12
Accepted
2020-06-12 11:58:02
Documents
14

Document Format Files

Seq Description Document Type Size
1 10-12G/A nugenerex061120form10a.htm 10-12G/A 541136
2 GRAPHIC image_001.jpg GRAPHIC 9810
3 EXHIBIT 10.1 ex10_1.htm EX-10.1 1084362
4 EXHI IT 10.2 ex10_2.htm EX-10.2 411186
5 EXHIBIT 10.3 ex10_3.htm EX-10.3 249896
6 GRAPHIC image_005.gif GRAPHIC 3285
7 GRAPHIC image_006.gif GRAPHIC 6923
8 GRAPHIC image_007.gif GRAPHIC 27186
9 GRAPHIC image_002.jpg GRAPHIC 17285
10 GRAPHIC image_004.gif GRAPHIC 19608
11 GRAPHIC image_001.gif GRAPHIC 41212
12 GRAPHIC image_002.gif GRAPHIC 51869
13 GRAPHIC image_003.gif GRAPHIC 15932
14 EXHIBIT 23.1 ex23_1.htm EX-23.1 2527
  Complete submission text file 0001607062-20-000154.txt   2556412
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 (416) 364-2551
NUGENEREX IMMUNO-ONCOLOGY, INC. (Filer) CIK: 0001804585 (see all company filings)

IRS No.: 043208418 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-12G/A | Act: 34 | File No.: 000-56153 | Film No.: 20959484
SIC: 2834 Pharmaceutical Preparations